Improving QoL in lymphoedema patients: De-risking LymphMotion.

Around 250 million people worldwide live with lymphoedema, yet 70% never receive the treatment they need. This project aims to change that by turning a bulky, clinic-bound therapy into something patients can wear at home. Lymphoedema is a chronic, incurable swelling that commonly follows cancer treatment. Managing it requires daily compression and frequent clinic visits using heavy, non-portable equipment—a burden that many patients simply cannot sustain. The result is unnecessary pain, reduced quality of life, and high costs for healthcare systems. The innovation is LymphMotion: a lightweight, wearable medical garment that lets patients self-manage their condition more comfortably and sustainably. This project will optimise an existing proof-of-concept prototype, de-risk the technology for wider use, and run public engagement activities to raise awareness of a condition that remains largely invisible. If successful, LymphMotion could shift lymphoedema care from intermittent clinic visits to continuous, home-based management. That would reduce pressure on healthcare services, cut patient travel and discomfort, and offer millions of people a practical way to live more independently with a lifelong condition.